Hereditary Angioedema Therapeutic Market Report

Global Hereditary Angioedema Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 13, 2021
  • PAGES：180
  • REPORT CODE：GMM645008
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Hereditary Angioedema Therapeutic is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Hereditary Angioedema Therapeutic market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Hereditary Angioedema Therapeutic industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Hereditary Angioedema Therapeutic Market Segmentations:

    By Players:

    • Novartis AG

    • CENTOGENE AG

    • Sanofi

    • CSL Limited

    • Pharming Group NV

    • Ionis Pharmaceuticals

    • KalVista Pharmaceuticals

    • BIOCRYST PHARMACEUTICALS, INC

    • Takeda Pharmaceutical Company Limited

    By Types:

    • Intravenous

    • Subcutaneous

    • Oral

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Hereditary Angioedema Therapeutic Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Intravenous from 2014 to 2026

      • 1.3.2 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Subcutaneous from 2014 to 2026

      • 1.3.3 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Oral from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Clinics from 2014 to 2026

      • 1.4.3 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Hereditary Angioedema Therapeutic Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Hereditary Angioedema Therapeutic Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Hereditary Angioedema Therapeutic by Major Types

      • 3.4.1 Hereditary Angioedema Therapeutic Market Size and Growth Rate of Intravenous

      • 3.4.2 Hereditary Angioedema Therapeutic Market Size and Growth Rate of Subcutaneous

      • 3.4.3 Hereditary Angioedema Therapeutic Market Size and Growth Rate of Oral

    4 Segmentation of Hereditary Angioedema Therapeutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Hereditary Angioedema Therapeutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hereditary Angioedema Therapeutic in Hospitals

      • 4.4.2 Market Size and Growth Rate of Hereditary Angioedema Therapeutic in Clinics

      • 4.4.3 Market Size and Growth Rate of Hereditary Angioedema Therapeutic in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Hereditary Angioedema Therapeutic Production Analysis by Major Regions

    • 5.2 Global Hereditary Angioedema Therapeutic Consumption Analysis by Major Regions

    • 5.3 Global Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

    6 Product Commodity of Hereditary Angioedema Therapeutic Market in Major Countries

    • 6.1 Top 5 Export Countries in Hereditary Angioedema Therapeutic market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Hereditary Angioedema Therapeutic market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Hereditary Angioedema Therapeutic Landscape Analysis

    • 7.1 North America Hereditary Angioedema Therapeutic Landscape Analysis by Major Types

    • 7.2 North America Hereditary Angioedema Therapeutic Landscape Analysis by Major End-Users

    • 7.3 North America Hereditary Angioedema Therapeutic Landscape Analysis by Major Countries

      • 7.3.1 United States Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 7.3.2 Canada Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 7.3.3 Mexico Hereditary Angioedema Therapeutic Market Volume and Growth Rate

    8 Europe Hereditary Angioedema Therapeutic Landscape Analysis

    • 8.1 Europe Hereditary Angioedema Therapeutic Landscape Analysis by Major Types

    • 8.2 Europe Hereditary Angioedema Therapeutic Landscape Analysis by Major End-Users

    • 8.3 Europe Hereditary Angioedema Therapeutic Landscape Analysis by Major Countries

      • 8.3.1 Germany Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.2 UK Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.3 France Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.4 Italy Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.6 Spain Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.7 Belgium Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.8 Poland Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.9 Russia Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 8.3.10 Turkey Hereditary Angioedema Therapeutic Market Volume and Growth Rate

    9 Asia Pacific Hereditary Angioedema Therapeutic Landscape Analysis

    • 9.1 Asia Pacific Hereditary Angioedema Therapeutic Landscape Analysis by Major Types

    • 9.2 Asia Pacific Hereditary Angioedema Therapeutic Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Hereditary Angioedema Therapeutic Landscape Analysis by Major Countries

      • 9.3.1 China Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 9.3.2 Japan Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 9.3.4 India Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 9.3.6 South Korea Hereditary Angioedema Therapeutic Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 10.3.2 Brazil Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 10.3.3 Nigeria Hereditary Angioedema Therapeutic Market Volume and Growth Rate

      • 10.3.4 South Africa Hereditary Angioedema Therapeutic Market Volume and Growth Rate 

      • 10.3.5 Argentina Hereditary Angioedema Therapeutic Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Novartis AG

      • 11.1.1 Novartis AG Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 CENTOGENE AG

      • 11.2.1 CENTOGENE AG Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Sanofi

      • 11.3.1 Sanofi Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 CSL Limited

      • 11.4.1 CSL Limited Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Pharming Group NV

      • 11.5.1 Pharming Group NV Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Ionis Pharmaceuticals

      • 11.6.1 Ionis Pharmaceuticals Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 KalVista Pharmaceuticals

      • 11.7.1 KalVista Pharmaceuticals Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 BIOCRYST PHARMACEUTICALS, INC

      • 11.8.1 BIOCRYST PHARMACEUTICALS, INC Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Takeda Pharmaceutical Company Limited

      • 11.9.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 107 Figures and 131 Tables)

    • Figure Product Picture

    • Figure Hereditary Angioedema Therapeutic Market Size and Growth Rate of Intravenous from 2014 to 2026

    • Figure Hereditary Angioedema Therapeutic Market Size and Growth Rate of Subcutaneous from 2014 to 2026

    • Figure Hereditary Angioedema Therapeutic Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Hereditary Angioedema Therapeutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Hereditary Angioedema Therapeutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Hereditary Angioedema Therapeutic by Different Types from 2014 to 2026

    • Table Consumption Share of Hereditary Angioedema Therapeutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Intravenous

    • Figure Market Size and Growth Rate of Subcutaneous

    • Figure Market Size and Growth Rate of Oral

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Hereditary Angioedema Therapeutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Hereditary Angioedema Therapeutic by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Table Global Hereditary Angioedema Therapeutic Production by Major Regions

    • Table Global Hereditary Angioedema Therapeutic Production Share by Major Regions

    • Figure Global Hereditary Angioedema Therapeutic Production Share by Major Regions in 2014

    • Figure Global Hereditary Angioedema Therapeutic Production Share by Major Regions in 2018

    • Figure Global Hereditary Angioedema Therapeutic Production Share by Major Regions in 2026

    • Table Global Hereditary Angioedema Therapeutic Consumption by Major Regions

    • Table Global Hereditary Angioedema Therapeutic Consumption Share by Major Regions

    • Figure Global Hereditary Angioedema Therapeutic Consumption Share by Major Regions in 2014

    • Figure Global Hereditary Angioedema Therapeutic Consumption Share by Major Regions in 2018

    • Figure Global Hereditary Angioedema Therapeutic Consumption Share by Major Regions in 2026

    • Table North America Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

    • Table Europe Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Hereditary Angioedema Therapeutic market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Hereditary Angioedema Therapeutic Consumption by Types from 2014 to 2026

    • Table North America Hereditary Angioedema Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Types in 2014

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Types in 2018

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Types in 2026

    • Table North America Hereditary Angioedema Therapeutic Consumption by End-Users from 2014 to 2026

    • Table North America Hereditary Angioedema Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2014

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2018

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2026

    • Table North America Hereditary Angioedema Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table North America Hereditary Angioedema Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2014

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2018

    • Figure North America Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2026

    • Figure United States Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption by Types from 2014 to 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Types in 2014

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Types in 2018

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Types in 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2014

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2018

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Europe Hereditary Angioedema Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2014

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2018

    • Figure Europe Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2026

    • Figure Germany Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure France Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption by Types from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Types in 2014

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Types in 2018

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Types in 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2014

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2018

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2026

    • Figure China Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandHereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure India Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Therapeutic Consumption Share by Major Countries in 2026

    • Figure GCC Countries Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Hereditary Angioedema Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of CENTOGENE AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CENTOGENE AG

    • Figure Sales and Growth Rate Analysis of CENTOGENE AG

    • Figure Revenue and Market Share Analysis of CENTOGENE AG

    • Table Product and Service Introduction of CENTOGENE AG

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of CSL Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited

    • Figure Sales and Growth Rate Analysis of CSL Limited

    • Figure Revenue and Market Share Analysis of CSL Limited

    • Table Product and Service Introduction of CSL Limited

    • Table Company Profile and Development Status of Pharming Group NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharming Group NV

    • Figure Sales and Growth Rate Analysis of Pharming Group NV

    • Figure Revenue and Market Share Analysis of Pharming Group NV

    • Table Product and Service Introduction of Pharming Group NV

    • Table Company Profile and Development Status of Ionis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals

    • Table Product and Service Introduction of Ionis Pharmaceuticals

    • Table Company Profile and Development Status of KalVista Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of KalVista Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of KalVista Pharmaceuticals

    • Figure Revenue and Market Share Analysis of KalVista Pharmaceuticals

    • Table Product and Service Introduction of KalVista Pharmaceuticals

    • Table Company Profile and Development Status of BIOCRYST PHARMACEUTICALS, INC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCRYST PHARMACEUTICALS, INC

    • Figure Sales and Growth Rate Analysis of BIOCRYST PHARMACEUTICALS, INC

    • Figure Revenue and Market Share Analysis of BIOCRYST PHARMACEUTICALS, INC

    • Table Product and Service Introduction of BIOCRYST PHARMACEUTICALS, INC

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US